Since our observations suggested that KLF10 expression increased with progression of NASH fibrosis and repressed as fibrosis regressed, in vitro study using primarily cultured hepatic stellate cells (HSCs), key players of liver fibrosis, was done. The gene discussed is KLF10; the disease is metabolic dysfunction-associated steatohepatitis.